PitchBook News - How resilient is healthcare, really?

Read online | Don't want to receive these emails? Manage your subscription.

Log in

The Weekend Pitch

January 15, 2023

Presented by the U.S. National Science Foundation

(Jenna O'Malley/PitchBook News)

It was perhaps apt that I had a migraine on one of the days I spent covering JP Morgan's healthcare conference this past week in San Francisco. I've suffered from this benign, but often debilitating, condition for a big part of my life. Over the years, I've spent tens of thousands of dollars out of pocket—a fraction of what it cost my health insurance—trying to manage the pain.

At a time when tech executives are bracing for a slowdown in revenue growth, many at the JPM conference sought to remind investors of the economic resilience of their sector by emphasizing that illnesses, either acute or chronic like mine, don't disappear during economic downturns. JP Morgan said in its earnings call on Friday that the bank's economists are expecting a mild recession to hit in the fourth quarter of this year.

However, most digital health and device companies aren't expecting revenue pressure. The same goes for pharmaceuticals with FDA-approved drugs. "Healthcare spend is mostly fixed," as one investor told me this week.

The objective for these companies has always been to capture a bigger slice of the enormous "fixed" pie, which in 2021 accounted for over 18% of US GDP. Nevertheless buzzwords like "margin expansion" and "path to profitability" were the phrases du jour heard from established public and VC-backed companies alike.

This is The Weekend Pitch, and I'm Marina Temkin. You can reach me at marina.temkin@pitchbook.com or on Twitter @MTemkin.

Trivia

VC exit activity declined significantly in 2022 amid market headwinds and rising inflation, generating only $71.4 billion. This is the first time exits have come up short of $100 billion since:

A) 2019
B) 2011
C) 2016
D) 2018

Find your answer at the bottom of The Weekend Pitch!

The long goodbye for VCs in Q4

Last year brought with it all kinds of highs and lows for VCs and startups alike. The highs of 2021 carried throughout the year, but began to fade in the waning months. Fundraising reached record highs, but exit activity hit decade lows.

Find out the details behind these dizzy trends in our Q4 2022 PitchBook-NVCA Venture Monitor.

Private credit rescued US PE in 2022

When many traditional lenders pulled back from the LBO market, it could have halted dealmaking—but the PE industry adjusted. Leveraged deals shrank overall and found backing from less-typical sources; growth-equity deals, which often don't require debt, gained popularity.

Explore how the industry churned along in 2022—despite strong headwinds—in our 2022 Annual US PE Breakdown.

Checking in on comparables

The trials and tribulations of the public markets are a sign of things to come for private companies.

Our latest series of public valuation guides breaks down recent stock performance, revenue forecasts and market caps of stock exchange giants to provide a glimpse into what's in store for the private markets in the coming year.

Check out the three guides:

Quote/Unquote

Janet Yellen
(Andrew Burton/Getty Images)

"Failure to meet the government's obligations would cause irreparable harm to the US economy, the livelihoods of all Americans, and global financial stability."

—Treasury secretary Janet Yellen in a letter to House Speaker Kevin McCarthy on the US hitting its impending debt limit.

Stay tuned

Keep an eye out for these insights and research reports coming out this week.

Sustainable and Digital Infrastructure in the Private Markets

2022 Annual European PE Breakdown

2023 JP Morgan Healthcare Conference Recap

2022 Annual European Venture Report

The Role of Placement Agents in GP Fundraising

Trivia

(Net Vector/Shutterstock)

Answer: C)

In 2022, exit activity dipped below $100 billion for the first time since 2016, according to PitchBook data. Learn more in the Q4 2022 PitchBook-NVCA Venture Monitor.

This edition of The Weekend Pitch was written by Marina Temkin, Emily Burleson and Jacob Robbins. It was edited by Alexander Davis and Sam Steele.

Were you forwarded The Weekend Pitch? Sign up at pitchbook.com/subscribe.

Since yesterday, the PitchBook Platform added:

118

People

69

Companies

See what our data software can do

About PitchBook | Terms of use | Advertise with us | Contact

This email was sent to you via the PitchBook Platform.

Do you want to change your email address, get a different edition or unsubscribe? Manage your subscription here.

US National Science Foundation The Weekend Pitch public market comparables

PitchBook News - How resilient is healthcare, really?

Trivia

The long goodbye for VCs in Q4

Private credit rescued US PE in 2022

Checking in on comparables

Quote/Unquote

Stay tuned

Recommended Reads

Trivia

Key phrases

Older messages

Why is VC dry powder still piling up?

The future of infrastructure investing

Europe's fintech startups to watch

European VC misses the mark

A fresh look at fund performance

You Might Also Like

Convincing loyal customers of a competitor

👀 The MF Who Ruined Search

Diamonds are not forever

🔍 Short Form Vid Structure & Landing Page Tactics

So, about my last email

Witness the AI power for yourself: Join our training LIVE!

Jons Growth Journal Issue #3 - why I'm avoiding short form content, side hustle updates, YouTube Channnel

Alternative to Google Traffic?

Digiday's annual guide to ad-supported streaming services, from the top platforms to marketing spend

♦️ Why your brand needs an enemy to grow faster (and how to choose one)